Delivery Order SPE2DR25D2217-SPE2DR26FC7CQ
- Not listed
- The Defense Logistics Agency awarded a $8,014.93 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Jatenzo 237 mg capsules (120-count units). This non-set-aside, competitively awarded contract features firm fixed price terms with an ultimate completion date of December 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city....
- The Defense Logistics Agency awarded a delivery order valued at $2,191.62 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Jatenzo 237 mg capsules (120-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 10, 2025, with performance based in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child order under a larger contract vehicle. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Jatenzo 237 mg capsules (120-count units) under a firm fixed-price contract with a ceiling value of $1,095.81. This non-set-aside competitive award is scheduled for completion by December 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jatenzo 237 mg capsules (120 count), with a ceiling value of $2,479.28. This competitive delivery order, issued with firm fixed pricing, represents a non-set-aside award and is scheduled for ultimate completion by August 14, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Jatenzo 158 mg capsules (120-count) with a ceiling value of $1,261.16. This competitive award, which was not set-aside, represents a firm fixed-price delivery order with an ultimate completion date of November 4, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Jatenzo 198 mg capsules (120 count). This is a firm fixed-price delivery order with a ceiling value of $1,292.51 and an ultimate completion date of July 31, 2025. The contract is not set aside and represents a competitive award to the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Jatenzo 158 mg capsules (120-count units) with a ceiling value of $1,095.80. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by December 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within the company's...
- The Defense Logistics Agency awarded a $1,131.88 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Jatenzo 158 mg capsules (120-count unit). This firm fixed-price delivery order, which is a child contract under a larger vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. The award utilized no set-aside designation and was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Jatenzo 198 mg capsules (120-count units) with a ceiling value of $1,443.58. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award to the prime contractor and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 6, 2025....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Jatenzo 237 mg capsules (120 count). This is a firm fixed-price delivery order with a ceiling value of $13,562.46 and an ultimate completion date of August 27, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's...
- SPE2DR25D2217Indefinite Delivery Contract
- SPE2DR25D2217-SPE2DR26FC7CQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Jatenzo 237 mg capsules (120-count units) under a firm fixed-price contract with a ceiling value of $1,178.07. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 9, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards with DLA demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and specialized healthcare commodities. All reviewed contract awards reflect competitive procurement practices with firm fixed-price delivery orders, positioning AmerisourceBergen as a versatile supplier capable of meeting federal medical supply needs across varying transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/7/25 |